AstraZeneca Opens Biomethane Plant in UK To Cut Emissions
AstraZeneca has opened a plant to produce biogas from organic waste that will ensure by the end of this year all of its research and development and drug manufacturing in Britain is powered by clean energy, it said on Thursday.
The plant, operated through a 15-year agreement between AstraZeneca and UK-based biomethane producer Future Biogas, will supply 100 gigawatt hours (GW) of renewable energy per year for AstraZeneca's three R&D and manufacturing sites in the country, equivalent to 20% of its total gas consumption globally.